|
|
|
Insider
Information: |
Silvernail Lauren P |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
207,068 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,840,846 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
207,068 |
|
|
Total
Value |
$1,840,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-60.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ISTA Pharmaceuticals Inc |
ISTA |
CFO & VP Corporate Dev... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
Revance Therapeutics, Inc. |
RVNC |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
See Remarks |
2022-05-18 |
141,571 |
2018-05-29 |
0 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HARP |
Harpoon Therapeutics, Inc... |
|
|
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-05-18 |
4 |
S |
$12.42 |
$646,026 |
D/D |
(52,015) |
141,571 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-05-17 |
4 |
S |
$13.92 |
$225,354 |
D/D |
(16,189) |
193,586 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-03-08 |
4 |
AS |
$9.73 |
$99,121 |
D/D |
(10,192) |
209,775 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
53,571 |
219,967 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-08-10 |
4/A |
AS |
$11.18 |
$159,774 |
D/D |
(14,293) |
166,396 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-08-10 |
4 |
S |
$11.18 |
$159,774 |
D/D |
(14,293) |
194,982 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
180,689 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-01-25 |
4 |
AS |
$7.46 |
$20,135 |
D/D |
(2,699) |
90,689 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2020-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
93,388 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
53,388 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2019-05-31 |
4 |
S |
$13.53 |
$35,352 |
D/D |
(2,612) |
27,388 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO & CBO |
|
2018-05-22 |
4 |
AS |
$30.25 |
$86,924 |
D/D |
(2,874) |
65,497 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-22 |
4 |
AS |
$30.85 |
$105,839 |
D/D |
(3,431) |
68,371 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-15 |
4 |
D |
$31.65 |
$36,461 |
D/D |
(1,152) |
71,802 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-13 |
4 |
AS |
$34.50 |
$892,412 |
D/D |
(25,867) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-13 |
4 |
OE |
$8.70 |
$225,043 |
D/D |
25,867 |
98,821 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-09 |
4 |
OE |
$8.70 |
$87,000 |
D/D |
10,000 |
82,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-09 |
4 |
AS |
$32.50 |
$325,000 |
D/D |
(10,000) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-07 |
4 |
AS |
$31.50 |
$315,000 |
D/D |
(10,000) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-07 |
4 |
OE |
$8.70 |
$87,000 |
D/D |
10,000 |
82,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-02-15 |
4 |
D |
$31.75 |
$36,068 |
D/D |
(1,136) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,125 |
74,090 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|